Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921707> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q61921707 description "assaig clínic" @default.
- Q61921707 description "clinical trial" @default.
- Q61921707 description "clinical trial" @default.
- Q61921707 description "clinical trial" @default.
- Q61921707 description "clinical trial" @default.
- Q61921707 description "ensaio clínico" @default.
- Q61921707 description "ensayo clínico" @default.
- Q61921707 description "ensayu clínicu" @default.
- Q61921707 description "essai clinique" @default.
- Q61921707 description "klinisch onderzoek" @default.
- Q61921707 description "клінічне випробування" @default.
- Q61921707 name "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921707 type Item @default.
- Q61921707 label "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921707 prefLabel "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921707 P1050 Q61921707-AEBD5757-71C6-41EE-A78A-A0784B4B6BBB @default.
- Q61921707 P1132 Q61921707-403AE7A8-33C5-4282-95C3-7826D6124F3E @default.
- Q61921707 P1476 Q61921707-34EEAF86-6ECB-4363-B76A-82FCB6E917FB @default.
- Q61921707 P2899 Q61921707-B1560A06-5819-448E-B423-343C38578B17 @default.
- Q61921707 P3098 Q61921707-E581ABC7-CBE5-4B1A-B4FF-5086D894D256 @default.
- Q61921707 P31 Q61921707-34FC9E4C-8E46-49A6-AC61-B95059F33D03 @default.
- Q61921707 P4844 Q61921707-5512C8B8-3843-49B2-99D9-B8AAE4252914 @default.
- Q61921707 P580 Q61921707-86CEA284-DF75-4659-A247-DD6BD38D5983 @default.
- Q61921707 P6099 Q61921707-682A3BA7-3EBD-4A7B-AAE0-606EF637206D @default.
- Q61921707 P8363 Q61921707-1E278F74-A632-444E-9F3B-9F0520D934CE @default.
- Q61921707 P859 Q61921707-893A1AA5-A3B9-48EB-B0C6-E25A5C5D9D30 @default.
- Q61921707 P1050 Q41861 @default.
- Q61921707 P1132 "+186" @default.
- Q61921707 P1476 "Ambrisentan in PAH - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension." @default.
- Q61921707 P2899 "+18" @default.
- Q61921707 P3098 "NCT00423202" @default.
- Q61921707 P31 Q30612 @default.
- Q61921707 P4844 Q410789 @default.
- Q61921707 P580 "2003-12-01T00:00:00Z" @default.
- Q61921707 P6099 Q42824827 @default.
- Q61921707 P8363 Q78089383 @default.
- Q61921707 P859 Q663596 @default.